Michael Boffa, M.D.
Neurology Physician in New York, New York. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 19,866 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Michael Boffa, M.D. reported a CMS MIPS final score of 84.5/100 - above the 83.1 national average - and filed 1,146 Medicare Part D claims in 2023.
- 84.5/100
- MIPS score · +1 vs avg
- 1K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Boffa, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
85 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Boffa, M.D. sits
This provider among neurology physician peers
Across the 5,437 neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Boffa, M.D. writes more Part D claims than 52% of them and scores higher on MIPS quality than 49% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neurology physician peer from a representative sample of 60; the gold marker is Michael Boffa, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Michael Boffa, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Boffa, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Neurology Physician compares to other specialties among New York providers
Neurology Physician ranks #52 among New York's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Neurology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Michael Boffa, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average
- MIPS Final Score
- 84.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neurology Physician) - 84.5/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Neurology Physician US NPIs
84.5/100 MIPS final score - 1.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Neurology Physician. Quality dim: 93.3. Cost dim: 54.9.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Boffa, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 550 FIRST AVENUE, New York, NY, 10016, with a listed phone of (212) 263-5506. NPI 1750676177 was issued on 06/14/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Boffa most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,146 prescription claims written by this provider, covering 160 Medicare beneficiaries and totaling roughly $283K in drug spend, split 14% brand-name and 84% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.5/100 for the 2023 performance year (Quality 93.3, Cost 54.9), compared with the national average of 83.1.
Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1750676177 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/14/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Michael Boffa, M.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Michael Boffa, M.D.. To verify Michael Boffa, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
14% brand-name claims vs 84% generic, on 1,146 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,470
- Total Day Supply
- 43,367
- Brand vs Generic
- 14% brand / 84% generic
- Brand Drug Cost
- $234K
- Generic Drug Cost
- $49K
Patient Demographics
- Average Patient Age
- 63.3 years
- Avg HCC Risk Score
- 1.91
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 70, 65-74: 51, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Boffa, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levetiracetam
Levetiracetam
207 claims
- Lamotrigine 64
Lamotrigine
64 claims
- Topiramate 59
Topiramate
59 claims
- Lacosamide 55
Lacosamide
55 claims
- Oxcarbazepine 45
Oxcarbazepine
45 claims
- Briviact 44
Briviact
44 claims
- Gabapentin 43
Gabapentin
43 claims
- Quetiapine Fumarate 37
Quetiapine Fumarate
37 claims
| Drug | Claims |
|---|---|
| Levetiracetam | 207 |
| Lamotrigine | 64 |
| Topiramate | 59 |
| Lacosamide | 55 |
| Oxcarbazepine | 45 |
| Briviact Brivaracetam | 44 |
| Gabapentin | 43 |
| Quetiapine Fumarate | 37 |
| Amitriptyline Hcl | 33 |
| Levetiracetam Er Levetiracetam | 32 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How Michael Boffa, M.D. fits within the Neurology Physician landscape nationally.
Michael Boffa, M.D.'s 1,146 claims are below the specialty average of 1,309.
Nearby Neurology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Boffa.
Compare Neurology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neurology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is Michael Boffa, M.D.'s specialty? ▼
How much does Michael Boffa, M.D. prescribe under Medicare Part D? ▼
What is Michael Boffa, M.D.'s Medicare quality score? ▼
Where is Michael Boffa, M.D. located? ▼
What is Michael Boffa, M.D.'s NPI number? ▼
Does Michael Boffa, M.D. prescribe more brand-name or generic drugs? ▼
How many Neurology Physician providers are there in the US? ▼
What drugs does Michael Boffa, M.D. prescribe most often? ▼
Does Michael Boffa, M.D. accept Medicare? ▼
How can I verify Michael Boffa, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology